Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Insulin lispro U100 by Adocia for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Insulin lispro U100 is under clinical development by Adocia and currently in Phase II for Type 1 Diabetes (Juvenile Diabetes)....
Data Insights
(Insulin lispro + pramlintide) by Adocia for Obesity: Likelihood of Approval
(Insulin lispro + pramlintide) is under clinical development by Adocia and currently in Phase I for Obesity. According to GlobalData,...